10x Genomics, Inc.·4

Dec 23, 4:26 PM ET

CRUTCHFIELD BRADFORD 4

4 · 10x Genomics, Inc. · Filed Dec 23, 2021

Insider Transaction Report

Form 4
Period: 2021-12-21
CRUTCHFIELD BRADFORD
Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2021-12-21$1.20/sh+4,688$5,62647,743 total
  • Exercise/Conversion

    Class A Common Stock

    2021-12-21$5.04/sh+49,910$251,54697,653 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-12-214,6880 total
    Exercise: $1.20Exp: 2027-10-18Class A Common Stock (4,688 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-12-2149,91061,757 total
    Exercise: $5.04Exp: 2028-11-02Class A Common Stock (49,910 underlying)
Footnotes (2)
  • [F1]This option, originally for 25,000 shares, of which 25,000 shares have been exercised, vested as to 1/48th of the shares on October 1, 2017, and 1/48th of the shares subject to the option vested each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
  • [F2]This option, originally for 125,000 shares, of which 63,243 shares have been exercised, vested as to 1/48th of the shares on October 1, 2018, and 1/48th of the shares subject to the option vested each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4